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Eicosanoid production by macrophages is an early response to
microbial infection that promotes acute inflammation. The
intracellular pathogen Listeria monocytogenes stimulates
arachidonic acid release and eicosanoid production from resident mouse peritoneal macrophages through activation of
group IVA cytosolic phospholipase A2 (cPLA2␣). The ability of
wild type L. monocytogenes (WTLM) to stimulate arachidonic
acid release is partially dependent on the virulence factor listeriolysin O; however, WTLM and L. monocytogenes lacking listeriolysin O (⌬hlyLM) induce similar levels of cyclooxygenase 2.
Arachidonic acid release requires activation of MAPKs by
WTLM and ⌬hlyLM. The attenuated release of arachidonic acid
that is observed in TLR2ⴚ/ⴚ and MyD88ⴚ/ⴚ macrophages
infected with WTLM and ⌬hlyLM correlates with diminished
MAPK activation. WTLM but not ⌬hlyLM increases intracellular calcium, which is implicated in regulation of cPLA2␣. Prostaglandin E2, prostaglandin I2, and leukotriene C4 are produced
by cPLA2␣ⴙ/ⴙ but not cPLA2␣ⴚ/ⴚ macrophages in response to
WTLM and ⌬hlyLM. Tumor necrosis factor (TNF)-␣ production is significantly lower in cPLA2␣ⴙ/ⴙ than in cPLA2␣ⴚ/ⴚ
macrophages infected with WTLM and ⌬hlyLM. Treatment of
infected cPLA2␣ⴙ/ⴙ macrophages with the cyclooxygenase
inhibitor indomethacin increases TNF␣ production to the
level produced by cPLA2␣ⴚ/ⴚ macrophages implicating prostaglandins in TNF␣ down-regulation. Therefore activation of
cPLA2␣ in macrophages may impact immune responses to
L. monocytogenes.

The human pathogen Listeria monocytogenes promotes disease through ingestion of contaminated food, and primarily
affects individuals with a suppressed immune system (1). L.

monocytogenes gains entry through the intestinal tract but can
traverse the blood-brain barrier and placenta to infect the brain
and fetus resulting in high mortality. L. monocytogenes invades
and replicates in a variety of cell types where it shelters itself
intracellularly from host antibodies and complement (2). L.
monocytogenes has been used extensively as a model organism
to study host-pathogen interactions (3).
A number of virulence factors have been identified that contribute to the ability of L. monocytogenes to replicate intracellularly and infect neighboring cells (4). Once L. monocytogenes
has invaded cells, the virulence factor listeriolysin O (LLO)2
perforates phagocytic vacuoles, which is essential for escape
into the cell cytosol (5–7). Two bacterial phospholipases C
(PLC), a phosphatidylinositol-specific PLC (PI-PLC) and broad
range PLC (BR-PLC), also contribute to escape of L. monocytogenes from these primary vacuoles (8 –11). Once in the cytosol
the L. monocytogenes surface protein ActA polymerizes actin,
which propels L. monocytogenes through the cytosol and into
pseudopods that are engulfed by neighboring cells to form secondary vacuoles. Bacterial escape from these secondary vacuoles spreads infection (3, 12, 13).
In experimental systemic L. monocytogenes infection in mice,
the bacteria are rapidly cleared from the bloodstream and taken
up by the spleen and liver phagocytes. Resident macrophages in
the liver, Kupffer cells, play important roles in bacterial uptake
and in controlling L. monocytogenes infection (14). Resident
macrophages produce the cytokines interleukin (IL)-6, IL-12,
and tumor necrosis factor (TNF)-␣, which initiate pro-inflammatory responses that are important for recruiting neutrophils
to the liver to kill L. monocytogenes.
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cPLA2␣ Activation and Eicosanoid Production in Macrophages
Eicosanoid production is an early response to microbial
infection that can regulate innate immunity (15, 16). Eicosanoids are oxygenated metabolites of arachidonic acid that
exert their potent biological effects by binding to G-proteincoupled receptors (17). Arachidonic acid is metabolized
through the cyclooxygenase (COX) and lipoxygenase pathways
for the production of prostaglandins and leukotrienes, respectively. Leukotrienes induce acute inflammatory responses such
as increased vascular permeability and recruitment of granulocytes. Prostaglandins have pro-inflammatory effects by increasing vascular permeability but also exert immune-suppressive
effects (18). Resident peritoneal macrophages have been used
extensively as a model to study the regulation of arachidonic
acid release and eicosanoid production; however, these
responses have not been investigated thoroughly in the context
of bacterial infection. In this study we demonstrate that nonopsonized L. monocytogenes activates group IVA cytosolic phospholipase A2 (cPLA2␣) in resident peritoneal macrophages
resulting in arachidonic acid release and eicosanoid production. Optimal activation of cPLA2␣ involves the bacterial virulence factor LLO and host toll-like receptor 2 (TLR2). Our
results also demonstrate an important role for cPLA2␣ activation in suppression of TNF␣ production by macrophages
infected with L. monocytogenes, implicating eicosanoids in regulating immune responses to L. monocytogenes.

EXPERIMENTAL PROCEDURES
Materials—Pathogen-free ICR mice were obtained from
Harlan Sprague-Dawley and used for all experiments unless
otherwise specified. TLR2 and MyD88 knock-out mice
(C57BL/6) were generated as described previously (19), and
age-matched control C57BL/6 mice were obtained from Harlan
Sprague-Dawley. cPLA2␣⫺/⫺ mice were generated using 129
embryonic stem cells in a C57BL/6 strain as described previously (20). The mixed strain was backcrossed onto a Balb/c
background and used after 10 generations. All mice were used
between 5 and 10 weeks of age for macrophage isolation.
[5,6,8,9,11,12,14,15-3H]Arachidonic acid (specific activity 100
Ci/mmol) was from PerkinElmer Life Sciences. Fetal bovine
serum (Gemini Bio-Products) was heat-inactivated at 56 °C for
30 min before use. DMEM was from Cambrex BioScience
Walkersville, Inc. Hanks’ balanced salts solution was purchased
from Invitrogen. Human serum albumin was obtained from
Intergen. The cPLA2␣ inhibitor, pyrrolidine-2, was generously
provided by Dr. Michael Gelb (University of Washington, Seattle). Polyclonal antibody to cPLA2␣ was raised as described
(21). Antibodies to phosphorylated extracellular signal-regulated kinases (ERKs) and p38 were obtained from Cell Signaling
Technology, Inc. Polyclonal antibody to murine COX2 was
obtained from Cayman Chemical Co. Antibody to L. monocytogenes was obtained from Difco (BD Biosciences). Gentamicin
and latrunculin A were from Sigma. U0126 and SB202190 were
obtained from Calbiochem. Complete protease inhibitor tablets were obtained from Roche Diagnostics. Tryptic soy agar
and brain heart infusion broth were purchased from Fluka BioChemika and BD Biosciences, respectively. Cyto-Tox ONE
homogeneous membrane integrity assay kit was obtained from
Promega. Fura Red-AM was from Invitrogen.
FEBRUARY 22, 2008 • VOLUME 283 • NUMBER 8

Bacteria—Wild type L. monocytogenes (WTLM) (DPL10403S), LLO mutant (⌬hlyLM) (DP-L2161), double mutant
strain lacking PI-PLC and BR-PLC (⌬plcA⌬plcB) (DP-L1936),
triple mutant strain (⌬hly⌬plcA⌬plcB) (DP-L2319), and
WTLM expressing enhanced green fluorescent protein (EGFP)
(strain L3-L268) were used in this study. The strains were
stored as glycerol stocks at ⫺80 °C. L. monocytogenes were
grown overnight with shaking (250 rpm) at 37 °C in brain heart
infusion broth and then sub-cultured to an optical density of
0.6. Bacteria were washed once in PBS and resuspended in
serum-free DMEM containing 0.1% human serum albumin
(stimulation medium) for use in experiments.
Macrophage Isolation and Arachidonic Acid Release Assay—
Resident mouse peritoneal macrophages were obtained by peritoneal lavage using 8 ml of DMEM containing 10% heat-inactivated fetal bovine serum, 100 g/ml streptomycin sulfate, 100
units/ml penicillin G, and 2 mM glutamine (supplemented
DMEM) containing 10 units/ml heparin. Cells were plated at
5 ⫻ 105 cells/well (48-well plate) and incubated for 2 h at 37 °C
in a humidified atmosphere of 7.5% CO2 in air. Cells were
washed twice with calcium- and magnesium-free Hanks’ balanced salts solution to remove nonadherent cells followed by
one wash with supplemented DMEM. Macrophages were cultured in supplemented DMEM containing [3H]arachidonic
acid (0.1 Ci/250 l/well) for 16 –18 h at 37 °C. The cells were
washed twice with antibiotic-free stimulation medium to
remove unincorporated [3H]arachidonic acid, and then
infected with L. monocytogenes in stimulation medium. The
culture medium was removed at the indicated times after infection, centrifuged, and the amount of radioactivity in the supernatant measured by scintillation counting. The cell-associated
radioactivity was measured following solubilization of the
monolayer with 0.1% Triton X-100. The amount of radioactivity released into the culture medium was expressed as percent
of the total radioactivity incorporated (cell-associated plus
medium).
Cell Cytotoxicity Assay—Resident mouse peritoneal macrophages were plated in 96-well plates (0.16 ⫻ 106 cells/well) and
cultured as described above. The effect of L. monocytogenes on
macrophage viability was assayed using Cyto-Tox ONE homogeneous membrane integrity assay kit according to manufacturer’s protocol using the LS55 spectrofluorometer
(PerkinElmer Life Sciences). The macrophage culture medium
was collected at various times after infection with L. monocytogenes and 50 l used to determine the percent lactate dehydrogenase (LDH) release.
L. monocytogenes Uptake Assay—Macrophages plated at
0.5 ⫻ 106 cells/well (48-well plate) were cultured overnight in
complete medium and then incubated with WTLM and
⌬hlyLM (m.o.i. 25) in stimulation medium for 1 h. Macrophages were washed twice and incubated in stimulation
medium containing gentamicin (50 g/ml) for 30 min to kill
extracellular bacteria. After washing twice with PBS, macrophages were lysed with 0.1% Triton X-100 in PBS and the intracellular L. monocytogenes plated on tryptic soy agar plates. The
number of colony-forming units (CFU) was determined after
incubation of plates for 22–24 h at 37 °C. For comparing uptake
of L. monocytogenes by peritoneal macrophages from
JOURNAL OF BIOLOGICAL CHEMISTRY
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cPLA2␣⫹/⫹ and cPLA2␣⫺/⫺ mice, a similar protocol was used
except the macrophages were not incubated with gentamicin.
After a 1-h incubation with WTLM, the macrophages were
washed six times to remove extracellular L. monocytogenes following a protocol described previously (22).
Eicosanoid and Cytokine Analysis—Resident mouse peritoneal macrophages were plated as described for arachidonic acid
release assays but incubated overnight without [3H]arachidonic
acid. Macrophages were incubated with either WTLM or
⌬hlyLM for 1 h, washed, and incubated in stimulation medium
containing 50 g/ml gentamicin. The culture medium was harvested 3 h after infection, complete protease inhibitor tablet
(1⫻) added, and stored at ⫺20 °C. Eicosanoids in the culture
medium were quantified by enzyme-linked immunosorbent
assay (ELISA Tech, Aurora, CO). TNF␣ in the culture medium
was quantified by enzyme-linked immunosorbent assay (ELISA
Tech, Aurora, CO) and by Luminex assay, which gave similar
results.
Western Blots—Macrophages were washed twice in ice-cold
PBS and lysed in buffer containing 50 mM HEPES, pH 7.4, 150
mM sodium chloride, 10% glycerol, 1% Triton X-100, 1 mM
EGTA, 1 mM EDTA, 200 M sodium vanadate, 10 mM tetrasodium pyrophosphate, 100 mM sodium fluoride, 300 nM p-nitrophenyl phosphate, 1 mM phenylmethylsulfonyl fluoride, 10
g/ml aprotinin, and 10 g/ml leupeptin. After incubation on
ice for 30 min, cell lysates were centrifuged at 15,000 rpm for 15
min, and protein concentration in the supernatant was determined by the bicinchoninic acid method. Lysates were boiled
for 5 min after addition of Laemmli buffer, and then proteins
(10 –30 g) were resolved on 10% SDS-polyacrylamide gels.
After transfer, nitrocellulose membranes were incubated in
blocking buffer (20 mM Tris-HCl buffer, pH 7.6, containing 137
mM NaCl, 0.05% Tween, and 5% nonfat milk), and then incubated overnight at 4 °C with polyclonal antibodies to cPLA2␣,
COX2, phospho-ERKs, and monoclonal antibody to phosphop38. The membranes were incubated with horseradish peroxidase-linked secondary antibodies (1:5000) in blocking buffer
for 30 min at room temperature. The immunoreactive proteins
were detected using the Amersham Biosciences ECL system.
Production of Recombinant Adenovirus and Microscopy—
Macrophages (5 ⫻ 105) were plated onto glass-bottomed MatTek dishes in complete medium, incubated for 2 h, and then
washed three times. Enhanced cyan fluorescent proteincPLA2␣ (ECFP-cPLA2␣) was expressed in resident peritoneal
macrophages using recombinant adenovirus (23). Human
cPLA2␣ was cloned into the ECFP vector (Clontech), and Ala206 in ECFP was mutated to Lys to produce the monomeric
form. ECFP-cPLA2␣ was subcloned into pVQ CMV k-NpA
vector, and virus (AdECFP-cPLA2␣) was produced and purified
by ViraQuest Inc. (North Liberty, IA). Macrophages were incubated in stimulation medium (150 l) containing AdECFPcPLA2␣ for 2 h. Supplemented DMEM (1.0 ml) was added, and
the macrophages were incubated at 37 °C in 7.5% CO2 for 26 h.
Macrophages were washed and incubated in stimulation
medium with EGFP-WTLM (m.o.i. 25), and then fixed with 3%
paraformaldehyde in PBS containing 3% sucrose for 15 min as
described previously (23). In some experiments, paraformaldehyde-fixed macrophages infected with WTLM or ⌬hlyLM were
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probed with rabbit polyclonal antibody to L. monocytogenes followed by Texas Red-conjugated secondary antibody. Golgi was
visualized using a rabbit polyclonal antibody to Giantin followed by Texas Red-conjugated secondary antibody. Cells were
imaged on an inverted Zeiss 200M microscope with a 175-watt
xenon lamp using 63⫻ oil immersion objective. Images were
acquired using a CCD camera from Sensicam and data analyzed
using Intelligent Imaging Innovations Inc. (3I) software.
Calcium Imaging—Macrophages (5 ⫻ 105) plated onto glassbottomed MatTek dishes were cultured overnight, washed with
phenol red-free DMEM containing 2 mM probenecid and 25
mM HEPES, pH 7.4 (imaging medium), and then incubated in
imaging medium containing 5 M Fura Red-AM and 0.02% pluronic at room temperature. After 30 min, the macrophages
were washed three times and incubated in imaging medium for
an additional 30 min. L. monocytogenes strains were added, and
live cell imaging was carried out at room temperature using an
inverted Zeiss 200M microscope with a 40⫻ oil immersion
objective and a Fura Red long pass dichroic mirror and emission filter set (Chroma) for the calcium indicator. Cells were
illuminated at 403 and 490 nm (to detect calcium-bound and
calcium-free form of the Fura Red indicator, respectively).
Images were acquired using a CCD camera from Sensicam, and
data were analyzed using Intelligent Imaging Innovations Inc.
(3I) software.
Statistical Analysis—Statistics were calculated in GraphPad
using paired t test to obtain two-tailed p values.

RESULTS
L. monocytogenes Stimulates cPLA2␣-mediated Arachidonic
Acid Release from Resident Peritoneal Macrophages—Unopsonized WTLM stimulated arachidonic acid release from resident
mouse peritoneal macrophages at multiplicities of infection
(m.o.i.) in the range of 5–25 (bacteria:macrophage) (Fig. 1A).
An L. monocytogenes mutant strain lacking LLO (⌬hlyLM)
induced ⬃60% less arachidonic acid release than WTLM at 60
min after infection. The role of L. monocytogenes PLCs was also
investigated by testing the double mutant lacking PI-PLC and
BR-PLC, and the triple mutant strain lacking LLO, PI-PLC, and
BR-PLC. Results demonstrated that PLCs do not play a role in
stimulating arachidonic acid release because the response to
the double PLC mutant was identical to WTLM, and the
response to the triple mutant was identical to ⌬hlyLM (data not
shown). Arachidonic acid release induced by WTLM was
inhibited by the cPLA2␣ inhibitor pyrrolidine-2 (Fig. 1B) and
was reduced by 85% in cPLA2␣⫺/⫺ macrophages infected with
WTLM and was near background levels in cPLA2␣⫺/⫺ macrophages infected with ⌬hlyLM (Fig. 1C). Thus nonopsonized L.
monocytogenes stimulates cPLA2␣-mediated arachidonic acid
release from resident peritoneal macrophages that involves the
virulence factor LLO.
A time course illustrated that the release of arachidonic acid
increased continuously from 20 min to 3 h after WTLM infection (Fig. 2A). In contrast, arachidonic acid release increased up
to 60 min after ⌬hlyLM infection and then leveled off. The
amount of arachidonic acid released 20 min after infection with
WTLM and ⌬hlyLM was not significantly different, but by 40
min WTLM induced significantly higher levels of arachidonic
VOLUME 283 • NUMBER 8 • FEBRUARY 22, 2008
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adding gentamicin was 5-fold
greater from macrophages infected
with WTLM than those infected
with ⌬hlyLM suggesting that
cPLA2␣ remained more active in
macrophages infected with WTLM.
There was little additional release of
arachidonic acid from macrophages
infected with WTLM at 120 and 180
min after adding gentamicin, unlike
cultures without gentamicin (compare Fig. 2, A and C). The results
suggest that extracellular LLO contributes to cPLA2␣ activation at
these later time points as shown in
Fig. 2A.
Role of L. monocytogenes Internalization in Regulating cPLA2␣
Activation—The increased cPLA2␣
activation by WTLM could in part
be due to its ability to escape into
the cytosol and proliferate. Alternatively, LLO could play an extracellular role by inducing signals that contribute to cPLA2␣ activation. This
latter process would presumably
FIGURE 1. L. monocytogenes stimulates cPLA2␣-mediated arachidonic acid release from mouse peritoneal macrophages. Macrophages labeled with [3H]arachidonic acid were infected for 60 min with the indi- not be dependent on WTLM intercated m.o.i. of WTLM or ⌬hlyLM (A) or WTLM and ⌬hlyLM (m.o.i. 25) (B and C). B, macrophages were incubated nalization. Thus, experiments were
for 30 min with and without 5 M pyrrolidine-2 prior to adding WTLM. C, macrophages isolated from
cPLA2␣⫹/⫹ and cPLA2␣⫺/⫺ mice (C57BL/6/129 mixed strain) were used. Similar results were obtained with carried out to determine whether
macrophages isolated from cPLA2␣⫹/⫹ and cPLA2␣⫺/⫺ BALB/c mice. The amount of [3H]arachidonic acid internalization of WTLM and
released into the medium from infected and uninfected (Uninf.) macrophages was measured and expressed as ⌬hlyLM is required for stimulation
a percentage of the total incorporated radioactivity. The results are the averages of two independent experiof arachidonic acid release. It has
ments in triplicate ⫾ S.D.
been reported that inhibiting phosacid release. Because L. monocytogenes proliferates in tissue cul- phoinositide 3-kinase (PI 3-kinase) with wortmannin blocks
ture medium, LLO released from growing WTLM over time internalization of L. monocytogenes into epithelial cells (24). As
may promote toxicity in resident peritoneal macrophages. As shown in Fig. 3A, wortmannin also inhibited internalization of
shown in Fig. 2B, ⌬hlyLM was not cytotoxic during the 3 h of WTLM and ⌬hlyLM by resident peritoneal macrophages. This
infection. In contrast, WTLM at m.o.i. of 13 and 25 induced 38 inhibition was similar for WTLM and ⌬hlyLM (68 and 71%,
and 80% release of LDH, respectively, by 3 h. Therefore, the respectively) by 60 min after infection. In control macrophages,
release of arachidonic acid beyond 60 min by WTLM correlated not treated with wortmannin, there was greater uptake of
with cytotoxicity. The ability of WTLM and ⌬hlyLM to stimu- ⌬hlyLM (2.7 ⫻ 105 CFU/well) than WTLM (1.1 ⫻ 105 CFU/
late arachidonic acid release was investigated under conditions well). J774 macrophages have been reported to internalize
in which growth of extracellular L. monocytogenes was inhibited ⌬hlyLM to a greater extent than WTLM (25). Wortmannin
with gentamicin. When macrophage cultures were washed 1 h inhibited internalization to a greater extent than arachidonic
after addition of WTLM, and then incubated in the presence of acid release in response to WTLM suggesting that arachidonic
gentamicin for 2 h, cytotoxicity was prevented (data not acid release is in part stimulated extracellularly.
shown). To determine the effect of blocking extracellular
Because inhibition of PI 3-kinase could affect signaling pathgrowth on arachidonic acid release, macrophages labeled with ways that regulate cPLA2␣ activation, the effect of latrunculin
[3H]arachidonic acid were infected (m.o.i. 25) with L. monocy- A, which depolymerizes actin, on internalization of L. monocytogenes for 60 min, and the cultures were rinsed and then incu- togenes and arachidonic acid release was also determined (Fig.
bated in media containing gentamicin. The amount of arachi- 3B). Latrunculin A at 0.1 and 1 M inhibited internalization of
donic acid released into the culture medium was measured at 1, WTLM (47 and 87%, respectively) and ⌬hlyLM (59 and 85%,
2, and 3 h after adding gentamicin (Fig. 2C). During the initial respectively) to a similar extent. As observed for experiments in
60 min infection (no gentamicin), the level of arachidonic acid Fig. 3A, there was greater uptake of ⌬hlyLM (2.9 ⫻ 105 CFU/
released in response to WTLM and ⌬hlyLM was 9 and 3.5%, well) than WTLM (1.3 ⫻ 105 CFU/well) by control macrorespectively, similar to the results shown in Fig. 2A. After phages not treated with latrunculin A. There was a direct corremoving the culture medium and adding fresh medium con- relation between blocking internalization of ⌬hlyLM with
taining gentamicin, the release of arachidonic acid 60 min after latrunculin A and inhibition of arachidonic acid release, indiFEBRUARY 22, 2008 • VOLUME 283 • NUMBER 8
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and then diminishes by 120 min.
The MEK1 inhibitor U0126 and the
p38 inhibitor SB202190 significantly blocked arachidonic acid
release implicating a role for these
MAPKs in regulating cPLA2␣ activation in response to L. monocytogenes (Fig. 4B). In control experiments, the MAPK inhibitors did not
block internalization of L. monocytogenes (data not shown). cPLA2␣ is
phosphorylated by p38 and ERKs on
Ser-505, which causes a decrease in
electrophoretic mobility on SDSpolyacrylamide gels (27, 28). As
shown in Fig. 4, WTLM induced a
cPLA2␣ gel shift indicating phosphorylation on Ser-505. Preincubation of macrophages with either the
MEK1 or p38 inhibitors prior to
infection with L. monocytogenes had
no effect on Ser-505 phosphorylation. Treatment of macrophages
with both U0126 and SB202190 partially blocked the gel shift, suggesting that ERKs and p38 contribute to
the phosphorylation of cPLA2␣ in
response to L. monocytogenes. HowFIGURE 2. Time course of arachidonic acid release and cytotoxicity in response to WTLM and ⌬hlyLM. ever, the MAPK inhibitors signifiMacrophages were infected with WTLM and ⌬hlyLM (m.o.i. 25), and release of [3H]arachidonic acid (A) and LDH cantly blocked arachidonic acid
(B) was monitored at the indicated times after infection in the absence of gentamicin. C, [3H]Arachidonic release under conditions that did
acid-labeled macrophages were incubated with WTLM or ⌬hlyLM for 60 min, washed, and then incubated in
fresh medium containing 50 g/ml gentamicin. The amount of [3H]arachidonic acid released was determined not detectably inhibit cPLA2␣ Serafter the initial 60 min of infection in the absence of gentamicin in response to WTLM (f) or ⌬hlyLM (䡺), and 505 phosphorylation, suggesting
then at the indicated times after washing and addition of fresh medium containing gentamicin (50 g/ml). The
amount of [3H]arachidonic acid released into the medium from infected and uninfected cells was measured that MAPKs have additional roles in
and expressed as a percentage of the total incorporated radioactivity after subtracting background arachi- regulating arachidonic acid release
donic acid release from uninfected macrophages. The results are the averages of three experiments ⫾S.E. (A induced by L. monocytogenes.
and C) or the averages of two experiments ⫾S.D. (B). [3H]arachidonic acid release because of WTLM and ⌬hlyLM
Role of Calcium in Regulating
was insignificant at 20 min but was significantly (*, p ⬍ 0.05) higher in response to WTLM than ⌬hlyLM at 40 min
and thereafter (A).
cPLA2␣ Activation— cPLA2␣ is regulated by increases in concentracating that internalization of ⌬hlyLM is required for cPLA2␣ tions of intracellular calcium ([Ca2⫹]i) that binds to the C2
activation. However, there was significantly less inhibition of domain and promotes its translocation from cytosol to memarachidonic acid release by latrunculin A (0.1 and 1.0 M) from brane where it hydrolyzes arachidonic acid from phospholipid
macrophages infected with WTLM (22 and 62%, respectively) (29). To determine the role of extracellular calcium in regulatthan ⌬hlyLM (76 and 87%, respectively). Therefore, cPLA2␣ ing arachidonic acid release and internalization of L. monocyactivation by ⌬hlyLM is dependent on internalization, whereas togenes, macrophages were incubated in medium containing
internalization-dependent and -independent pathways are EGTA. Chelating extracellular calcium significantly blocked
involved in cPLA2␣ activation by WTLM. The results suggest both arachidonic acid release stimulated by WTLM and
that LLO exerts an extracellular effect on macrophages leading ⌬hlyLM (80 and 83%, respectively) and internalization (53
and 30%, respectively) (Fig. 5A). In control macrophages not
to greater stimulation of cPLA2␣.
Activation of MAPKs by L. monocytogenes Regulates Arachi- treated with EGTA, the numbers of intracellular ⌬hlyLM (3.9 ⫻
donic Acid Release—Activation of MAPKs regulates cPLA2␣- 105 CFU/well) were greater than WTLM (1.4 ⫻ 105 CFU/well).
mediated arachidonic acid release from resident peritoneal Although chelating extracellular calcium with EGTA tended to
macrophages in response to a variety of agonists (26). The abil- block internalization of WTLM to a greater extent than
ity of L. monocytogenes to activate MAPKs in resident perito- ⌬hlyLM, this did not reach statistical significance. The results
neal macrophages was investigated by Western blotting using suggest that calcium has a dual role and regulates cPLA2␣ actiphospho-specific antibodies to the activated forms of p38 and vation and internalization of L. monocytogenes. The ability of
p42/p44 ERKs (Fig. 4A). WTLM and ⌬hlyLM activated p38 and WTLM and ⌬hlyLM to induce increases in [Ca2⫹]i was comERKs to a similar extent, which occurs between 20 and 60 min pared (Fig. 5B). Live cell imaging of calcium mobilization over
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FIGURE 3. Role of L. monocytogenes internalization in regulating arachidonic acid release. [3H]Arachidonic acid-labeled (open bars) or unlabeled
macrophages (gray bars) were incubated in the absence or presence of 0.1 M
wortmannin (A), or 0.1 or 1.0 M latrunculin A (B) for 30 min. After 60 min of
incubation with WTLM and ⌬hlyLM (m.o.i. 25), [3H]arachidonic acid (AA)
release (open bars) or bacterial uptake (CFU) (gray bars) were measured. The
results are averages ⫾S.E. of a minimum of three independent experiments.
The data are expressed as the % inhibition relative to WTLM or ⌬hlyLM controls not treated with inhibitors. WTLM- and ⌬hlyLM-infected control macrophages released 18.5 and 10.5% AA (A) and 19.3 and 10.9% AA (B), respectively. There was significantly (*, p ⬍ 0.05) less inhibition of [3H]arachidonic
acid release by latrunculin A (0.1 and 1.0 M) from macrophages stimulated
with WTLM than ⌬hlyLM.

time in macrophages loaded with Fura Red-AM demonstrated
a heterogeneous response of individual cells to WTLM, but
increases in [Ca2⫹]i were evident in many cells ⬃10 min after
adding WTLM. The heterogeneous response may be due to the
timing and number of WTLM that interact with macrophages.
In contrast, increases in [Ca2⫹]i could not be detected in most
macrophages incubated with ⌬hlyLM.
We previously reported that cPLA2␣ translocates to the phagosome during internalization of zymosan by resident peritoneal macrophages (23). To determine whether this occurs during phagocytosis of L. monocytogenes, the subcellular
localization of ECFP-cPLA2␣ in macrophages infected with
WTLM or ⌬hlyLM was monitored (Fig. 5C). In uninfected
macrophages, ECFP-cPLA2␣ exhibited diffuse cytoplasmic
localization (Fig. 5C, panel A). Infection of macrophages with
WTLM and ⌬hlyLM caused considerable cell spreading (Fig.
FEBRUARY 22, 2008 • VOLUME 283 • NUMBER 8

FIGURE 4. Activation of ERKs and p38 by WTLM and ⌬hlyLM contributes
to cPLA2␣-mediated AA release. A, cell lysates were prepared from uninfected (Uninf.) or L. monocytogenes-infected macrophages (m.o.i. 25) at the
indicated times. Activation of MAPKs was determined by probing for phosphorylated p38 (p38-P) or ERKs (ERK-P) on Western blots using phosphospecific antibodies. The samples were probed for total ERK protein (panel 3) as a
control for sample loading. B, [3H]arachidonic acid-labeled macrophages
were preincubated with vehicle (Me2SO), 10 M U0126 for 15 min, or 10 M
SB202190 for 60 min followed by infection (m.o.i. 25) with WTLM or ⌬hlyLM
for 60 min. The amount of [3H]arachidonic acid released into the media is
expressed as a percentage of release from control macrophages (gray bars)
not treated with inhibitors (100%). WTLM- and ⌬hlyLM-infected control macrophages not treated with inhibitors released 18.6 and 8.4% AA, respectively.
C, cPLA2␣ gel shift was analyzed by immunoblotting lysates from macrophages treated as described above. Results are representative of two independent experiments (A and C) or the averages ⫾ S.E. of three independent
experiments (B). Arachidonic acid release was significantly lower (*, p ⬍ 0.05)
from macrophages treated with MAPK inhibitors compared with controls (B).

5C, panels B and C). In macrophages incubated with EGFPtagged WTLM, ECFP-cPLA2␣ localized to a juxtanuclear
region (Fig. 5C, panel B) indicative of Golgi, which was confirmed by showing co-localization with the Golgi marker Giantin (Fig. 5C, panels D–F). Localization of ECFP-cPLA2␣ to
membrane ruffles also occurred in infected macrophages. A
similar pattern of ECFP-cPLA2␣ localization was observed in
macrophages infected with ⌬hlyLM (Fig. 5C, panel C). There
was no evidence of ECFP-cPLA2␣ fluorescence surrounding
either WTLM or ⌬hlyLM, indicating that cPLA2␣ does not
translocate to the phagosome.
Arachidonic Acid Release Stimulated by L. monocytogenes
Involves TLR2 and MyD88—MyD88-deficient mice are highly
susceptible to L. monocytogenes infection; however, contradictory results have been reported for the involvement of TLR2 in
controlling infection (30 –32). The role of TLR2 and MyD88 in
regulating cPLA2␣ activation was investigated by comparing
the ability of L. monocytogenes to induce arachidonic acid
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 6. Role of TLR2 and MyD88 in regulating arachidonic acid release
in response to WTLM and ⌬hlyLM. [3H]Arachidonic acid-labeled resident
mouse peritoneal macrophages isolated from wild type (solid bars), TLR2⫺/⫺
(open bars) (A) or MyD88⫺/⫺ (open bars) (B) mice were infected (m.o.i. 25) with
WTLM or ⌬hlyLM for 60 min. The amount of [3H]arachidonic acid released into
the media is expressed as a percentage of release from wild type macrophages (100%). WTLM- and ⌬hlyLM-infected wild type macrophages
released 13.9 and 6.1% AA (A) and 23.2 and 12.5% AA (B), respectively. Results
are the averages ⫾ S.D. of two independent experiments.

FIGURE 5. Role of calcium in regulating cPLA2␣ activation by L. monocytogenes. A, [3H]arachidonic acid-labeled (gray bars) or unlabeled macrophages (open bars) were incubated in the absence or presence of 10 mM EGTA
for 15 min. After a 60-min incubation with WTLM and ⌬hlyLM (m.o.i. 25),
[3H]AA release or bacterial uptake (CFU) was measured. The amount of [3H]AA
released into the media is expressed as a percentage of release from control
macrophages (gray bars) not treated with EGTA (100%). WTLM- and ⌬hlyLMinfected macrophages not treated with EGTA released 21.4 and 8.8% AA,
respectively. The results are averages ⫾S.E. of three independent experiments. There was significantly (p ⬍ 0.05) less [3H]AA release and CFU from
macrophages in the presence of EGTA. B, macrophages loaded with Fura
Red-AM were incubated without (control) or with (m.o.i. 25) WTLM or ⌬hlyLM.
[Ca2⫹]i changes were determined by live cell imaging and calculated as a ratio
of the fluorescence intensities of bound to unbound calcium (F403/F490). Each
point is expressed relative to time 0 (Rt/R0). In the graph on the left, data from
16 to 25 control (solid black line) or ⌬hlyLM infected (solid red line) macrophages were averaged. For macrophages infected with WTLM, data from
individual macrophages are shown as different colored lines. In the graph on
the right, averages ⫾ S.E. are shown. C, macrophages expressing ECFPcPLA2␣ were incubated without (uninfected, panel A) or with (m.o.i. 25) EGFPWTLM (panel B) or ⌬hlyLM (panel C) for 60 min and then fixed for fluorescence
microscopy. For visualizing ⌬hlyLM (panel C) or WTLM shown in panels E and
F, macrophages were probed with antibody to L. monocytogenes. Panel D
shows macrophages expressing ECFP-cPLA2␣ (shown as pseudo-red) after
incubation with WTLM for 30 min. The same cell probed with rabbit polyclonal antibodies to the Golgi marker Giantin (pseudo-green) and to L. monocytogenes followed by Texas Red secondary antibody (shown as pseudogreen) is shown in panel E. Although the secondary antibody depicts both
Golgi and L. monocytogenes, bacteria are readily distinguished from Golgi
(arrow), where localization of cPLA2␣ is evident (overlay, panel F).

release from resident peritoneal macrophages isolated from
wild type, TLR2, or MyD88 knock-out mice. Arachidonic acid
release in response to WTLM and ⌬hlyLM was attenuated in
TLR2⫺/⫺ macrophages by 55 and 90%, respectively (Fig. 6A).
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FIGURE 7. TLR2 regulates p38 and ERK activation in macrophages
infected with WTLM and ⌬hlyLM. Resident mouse peritoneal macrophages
isolated from TLR2⫺/⫺ and TLR2⫹/⫹ mice were infected (m.o.i. 25) with WTLM
or ⌬hlyLM for 60 min (A) or for the times indicated (B). Activation of MAPKs
was determined by probing for phosphorylated p38 (p38-P) or ERKs (ERK-P)
on Western blots using phospho-specific antibodies. Uninf, uninfected.

The extent of L. monocytogenes internalization did not differ in
TLR2⫹/⫹ and TLR2⫺/⫺ macrophages (data not shown). As
shown in Fig. 6B, arachidonic acid release was attenuated to a
similar extent in MyD88⫺/⫺ macrophages as TLR2⫺/⫺ macrophages indicating that TLR2 is the principal MyD88-dependent
receptor involved in regulating cPLA2␣ activation in response
to L. monocytogenes. The attenuated release of arachidonic acid
from TLR2⫺/⫺ macrophages correlated with less activation of
p38 and p42/p44 ERKs in response to WTLM and ⌬hlyLM (Fig.
7A). The defect in the activation of these MAPKs in TLR2⫺/⫺
macrophages was evident from 20 to 120 min after addition of
L. monocytogenes (Fig. 7B).
COX2 Expression and Eicosanoid Production Induced by L.
monocytogenes—WTLM and ⌬hlyLM induced the expression
of COX2 to a similar extent with maximal up-regulation occurring 3 h after infection (m.o.i. 25) (Fig. 8A). Expression of COX2
induced by WTLM and ⌬hlyLM did not involve TLR2 because
VOLUME 283 • NUMBER 8 • FEBRUARY 22, 2008

cPLA2␣ Activation and Eicosanoid Production in Macrophages
similar levels of expression occurred in TLR2⫹/⫹ and TLR2⫺/⫺
macrophages (Fig. 8B). Levels of COX1 were unaffected in macrophages infected with L. monocytogenes and were similar in
TLR2⫹/⫹ and TLR2⫺/⫺ macrophages.
L. monocytogenes stimulated the production of PGE2, PGI2,
and LTC4 by cPLA2␣⫹/⫹ macrophages, but eicosanoid production was almost completely ablated in cPLA2␣⫺/⫺ macrophages (Fig. 9A). The level of prostanoids produced by
cPLA2␣⫹/⫹ macrophages 3 h after infection was lower in macrophages infected with ⌬hlyLM than WTLM, although this did
not reach statistical significance. However, WTLM stimulated
significantly more LTC4 production than ⌬hlyLM consistent
with the ability of WTLM to increase [Ca2⫹]i, which regulates
5-lipoxygenase activation. Thus some of the increased arachiFIGURE 8. COX2 expression is induced by WTLM and ⌬hlyLM and is inde- donic acid released by WTLM is diverted through the 5-lipoxypendent of TLR2. Resident mouse peritoneal macrophages isolated from ICR (A)
and TLR2⫺/⫺ and TLR2⫹/⫹ mice (B) were infected (m.o.i. 25) with WTLM or ⌬hlyLM. genase pathway.
Eicosanoids have been reported to differentially affect bacteAfter a 1-h incubation with L. monocytogenes, the macrophages were washed and
then incubated in medium containing gentamicin. Expression of COX2 and COX1 rial internalization. PGE suppresses phagocytosis of L. mono2
was determined by Western blotting of macrophage lysates prepared at the times
cytogenes but leukotrienes enhance phagocytosis of Klebsiella
indicated after addition of L. monocytogenes. Uninf, uninfected.
pneumoniae by macrophages (22,
33). cPLA2␣⫹/⫹ and cPLA2␣⫺/⫺
peritoneal macrophages were compared to determine whether the
decreased production of diverse
lipid mediators by cPLA2␣⫺/⫺ macrophages affects internalization of
WTLM. For these experiments,
CFUs were determined after incubation of macrophages with WTLM
for 60 min followed by extensive
washing to remove extracellular
bacteria, rather than using gentamicin, to compare our results with the
study of Hutchison and Myers (22).
To ensure that the washing procedure sufficiently removed extracellular WTLM, macrophages were
treated with latrunculin A, which
blocks WTLM internalization (Fig.
9B). Latrunculin A blocked WTLM
uptake by 90% indicating that the
CFU represent internalized bacteria
and not extracellular bacteria
bound to the cell surface. Using the
washing technique, the number of
WTLM internalized by cPLA2␣⫹/⫹
FIGURE 9. cPLA2␣ is required for eicosanoid production by macrophages infected with L. monocyto6
genes. A, resident peritoneal macrophages isolated from cPLA2␣⫹/⫹ and cPLA2␣⫺/⫺ mice (BALB/c) were incu- macrophages (1.3 ⫻ 10 CFU/well)
bated with WTLM or ⌬hlyLM (m.o.i. 25) for 60 min, washed, and then incubated in fresh medium containing was higher than obtained following
gentamicin. Levels of PGE2, 6-keto prostaglandin F1␣ (6-keto PGF1␣, the stable metabolite of PGI2), and leukotriene C4 (LTC4) were measured in the culture medium collected 3 h after adding L. monocytogenes. The results gentamicin treatment. Treating cell
are the averages ⫾ S.E. of five independent experiments for cPLA2␣⫹/⫹ macrophages and averages ⫾ S.D. of cultures with gentamicin is a comtwo experiments for cPLA2␣⫺/⫺ macrophages. There was significantly (*, p ⬍ 0.05) less LTC4 production by monly used protocol to kill extracelcPLA2␣⫹/⫹ macrophages infected with ⌬hlyLM than WTLM. B, resident peritoneal macrophages isolated from
cPLA2␣⫹/⫹ and cPLA2␣⫺/⫺ mice were incubated with or without (none) PGE2 (4 ng/ml), leukotriene C4 (10 lular L. monocytogenes and is essenng/ml), or latrunculin A (1 M) for 15 before addition of WTLM (m.o.i. 25). After incubation for 1 h, the macro- tial for preventing growth of
phages were washed six times and lysed with 0.1% Triton X-100 for determination of CFU. The results are the
extracellular bacteria during long
average ⫾ S.E. of at least three independent experiments. There was significantly (*, p ⬍ 0.05) less CFU in
untreated cPLA2␣⫺/⫺ macrophages than cPLA2␣⫹/⫹ macrophages and in PGE2- or LTC4-treated cPLA2␣⫺/⫺ term incubations. However, it has
macrophages than similarly treated cPLA2␣⫹/⫹ macrophages. There was significantly (**, p ⬍ 0.05) less CFU in been reported that gentamicin can
cPLA2␣⫹/⫹ macrophages treated with PGE2 and more CFU in cPLA2␣⫹/⫹ macrophages treated with LTC4
compared with untreated cPLA2␣⫹/⫹ macrophages (none). There was significantly (#, p ⬍ 0.05) less CFU in gain access to the phagosomal comcPLA2␣⫺/⫺ macrophages treated with PGE2 than in untreated cPLA2␣⫺/⫺ macrophages. Uninf, uninfected.
partment and contribute to killing
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sidering the importance of TNF␣ in regulating immune
responses to L. monocytogenes infection, we compared TNF␣
production by cPLA2␣⫹/⫹ and cPLA2␣⫺/⫺ macrophages in
response to L. monocytogenes. cPLA2␣⫺/⫺ macrophages produced significantly higher levels of TNF␣ than cPLA2␣⫹/⫹
macrophages (Fig. 10B). Treating cPLA2␣⫹/⫹ macrophages
with the COX inhibitor indomethacin increased TNF␣ production to the levels produced by cPLA2␣⫺/⫺ macrophages implicating a role for prostaglandins in suppressing TNF␣
production.

FIGURE 10. Regulation of TNF␣ production by prostaglandins. A, resident
peritoneal macrophages isolated from cPLA2␣⫹/⫹ mice were incubated for
30 min with or without 20 M indomethacin or 10 M NS398 and then incubated with WTLM for 3 h as described above for Fig. 9A. Control macrophages
not treated with inhibitors produced 9.9 ng/ml PGE2 and 9.1 ng/ml 6-keto
PGF1␣. B, cPLA2␣⫹/⫹ macrophages, incubated with or without 20 M indomethacin, and cPLA2␣⫺/⫺ macrophages incubated without indomethacin,
were treated as described in Fig. 9A. The culture media were collected 3 h
after adding WTLM or ⌬hlyLM for TNF␣ analysis. Results are the averages of
two independent experiments ⫾ S.D. (A) or the averages of three independent experiments ⫾ S.E. (B). cPLA2␣⫺/⫺ macrophages and indomethacintreated cPLA2␣⫹/⫹ macrophages produced significantly more (p ⬍ 0.05)
TNF␣ production than untreated cPLA2␣⫹/⫹ macrophages.

of intracellular L. monocytogenes, which may explain the higher
CFU obtained with the washing protocol (34). A comparison of
the number of internalized WTLM in cPLA2␣⫹/⫹ and
cPLA2␣⫺/⫺macrophages after incubation with bacteria for 60
min revealed that cPLA2␣⫺/⫺ macrophages internalized significantly fewer WTLM (25% less CFU) than cPLA2␣⫹/⫹ macrophages (Fig. 9B). The direct addition of PGE2, at a concentration in the range produced by cPLA2␣⫹/⫹ macrophages,
significantly blocked internalization of WTLM by cPLA2␣⫹/⫹
and cPLA2␣⫺/⫺ macrophages. In contrast, LTC4 addition
induced a small (15%) but significant increase in WTLM uptake
by cPLA2␣⫹/⫹ macrophages but not by cPLA2␣⫺/⫺ macrophages. Thus the decreased uptake of WTLM by cPLA2␣⫺/⫺
macrophages is not solely explained by the lack of LTC4
production.
cPLA2␣-mediated Prostaglandin Production Down-regulates
WTLM-stimulated TNF␣ Production—We investigated the
contribution of COX1 and COX2 in mediating prostaglandin
production in macrophages infected with WTLM. As shown in
Fig. 10A, the COX2 inhibitor NS398 blocked PGE2 and PGI2
production by 72 and 55%, respectively, whereas the nonselective COX inhibitor indomethacin blocked prostaglandin
production by over 90%. The results suggest a role for both
COX2 and COX1 in prostaglandin production in response to
L. monocytogenes.
Several reports have demonstrated a role for prostanoids in
regulating cytokine production by macrophages (35– 43). Con-
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DISCUSSION
The ability of L. monocytogenes to disseminate and evade
host responses is in part because of its ability to survive and
multiply within a variety of cell types, including tissue macrophages (2, 44, 45). The results of this study demonstrate that L.
monocytogenes stimulates cPLA2␣ activation and eicosanoid
production in resident peritoneal macrophages and occurs in
the absence of serum with un-opsonized bacteria. WTLM and
⌬hlyLM stimulate similar levels of arachidonic acid release at
early times (20 min), but at later times (40 – 60 min) WTLM
stimulates to a greater extent than ⌬hlyLM. The results demonstrate that LLO augments cPLA2␣ activation but is not
essential. In contrast, the activation of host phospholipases C
and D in J774 macrophages by WTLM is absolutely dependent
on LLO (46). The increased arachidonic acid release by WTLM
could in part be due to LLO-dependent escape from the primary phagosome and proliferation in the cytosol, which occurs
within the time frame observed for enhancement of arachidonic acid release by WTLM. However, if LLO-dependent
escape of WTLM from the primary vacuole or cell-to-cell
spread contributed to cPLA2␣ activation, we would have
expected the double PLC mutant to be less effective at inducing
arachidonic acid release because PLCs contribute to escape and
spread (8 –11). However, the double L. monocytogenes mutant
lacking PI-PLC and BR-PLC stimulated arachidonic acid
release as effectively as WTLM. Experiments also demonstrated that L. monocytogenes mutants lacking the virulence
factors p60, an autolysin that hydrolyzes peptidoglycan, and
ActA, a protein important for actin-based L. monocytogenes
motility, stimulated arachidonic acid release as effectively as
WTLM (data not shown) (47– 49).
Results using latrunculin A, which blocks internalization of
WTLM to a greater extent than arachidonic acid release, suggest that LLO may act extracellularly to promote cPLA2␣ activation. In contrast, arachidonic acid release induced by ⌬hlyLM
is more dependent on internalization than for WTLM. The
delay in the enhancement of arachidonic acid release by WTLM
may be due to the time-dependent production and secretion of
extracellular LLO to levels needed for augmenting arachidonic
acid release. LLO may play a signaling role at the plasma membrane in addition to its role in promoting escape of L. monocytogenes from the primary phagosome (3). Recent studies have
demonstrated that LLO exhibits cholesterol-dependent poreforming ability at physiological pH and may induce cell signaling by aggregating lipid rafts (50, 51). It has been shown that L.
monocytogenes-stimulated leukotriene production by human
neutrophils is completely dependent on LLO. It occurs indeVOLUME 283 • NUMBER 8 • FEBRUARY 22, 2008
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pendently of phagocytosis and by purified LLO (52). In macrophages, we find that both LLO-dependent and -independent
mechanisms contribute to cPLA2␣ activation. Heat-killed L.
monocytogenes also stimulated arachidonic acid release (data
not shown), although more weakly than ⌬hlyLM, suggesting
that a cell wall component of L. monocytogenes contributes to
cPLA2␣ activation.
To mediate arachidonic acid release, cPLA2␣ must translocate from the cytosol to the membrane to access substrate. This
is an important regulatory step induced by elevations in [Ca2⫹]i
that binds to the cPLA2␣ C2 domain increasing its affinity for
membrane (29, 53, 54). However, in response to certain stimuli
cPLA2␣-mediated arachidonic acid release from macrophages
occurs with no detectable increase in [Ca2⫹]i, although resting
levels of calcium are required (55–58). Previous studies have
shown that WTLM stimulates [Ca2⫹]i increases in endothelial
cells, epithelial cells, and J774 macrophages to a greater extent
than ⌬hlyLM, and that LLO forms calcium-permeable pores in
cells (25, 59 – 62). Similarly, we found in resident peritoneal
macrophages that WTLM but not ⌬hlyLM increases [Ca2⫹]i,
which may contribute to the ability of WTLM to stimulate
greater arachidonic acid release. However, arachidonic acid
release stimulated by ⌬hlyLM is blocked by chelating extracellular calcium. This suggests a role for resting [Ca2⫹]i, which
may be lowered by extracellular EGTA. It is also possible that
⌬hlyLM stimulates local, transient increases in [Ca2⫹]i that we
were not able to detect. During zymosan phagocytosis, cPLA2␣
translocates to the forming phagosome, membrane ruffles, and
Golgi (23). Similarly, cPLA2␣ translocates to Golgi and membrane ruffles in macrophages infected with L. monocytogenes.
However, we found no evidence that cPLA2␣ translocates to
the L. monocytogenes phagosome suggesting differences in the
properties of the phagosome membrane.
Activation of cPLA2␣ in resident peritoneal macrophages is
partially dependent on engagement of TLR2 by L. monocytogenes. Arachidonic acid release is more dependent on TLR2 in
response to ⌬hlyLM than to WTLM, consistent with a TLR2independent role for LLO in cPLA2␣ activation in response to
WTLM. Resident peritoneal macrophages lacking MyD88
exhibited a similar decrease in arachidonic acid release as
TLR2⫺/⫺ macrophages, in response to WTLM and ⌬hlyLM.
This suggests that TLR2 engagement is the principal MyD88dependent pathway involved in regulating cPLA2␣ activation in
response to L. monocytogenes. Our results demonstrate that
TLR2 is required for optimal activation of ERKs and p38, which
regulate activation of cPLA2␣-mediated arachidonic acid
release in response to L. monocytogenes. In contrast to reports
using nonphagocytic cells, MAPKs are activated to a similar
extent by WTLM and ⌬hlyLM in peritoneal macrophages, and
are not required for L. monocytogenes internalization (63– 65).
MAPKs (ERKs and p38) phosphorylate cPLA2␣ on Ser-505,
which enhances activity of cPLA2␣ and promotes arachidonic
acid release (27, 28, 66). L. monocytogenes induces the stoichiometric phosphorylation of cPLA2␣ on Ser-505 as evidenced by
the complete shift in electrophoretic mobility on SDS-polyacrylamide gels. However, inhibition of either ERKs or p38
blocked L. monocytogenes-induced arachidonic acid release
under conditions that did not prevent phosphorylation of
FEBRUARY 22, 2008 • VOLUME 283 • NUMBER 8

cPLA2␣ on Ser-505. These results suggest an additional role
independent of Ser-505 phosphorylation for MAPKs in regulating cPLA2␣ in response to L. monocytogenes, as observed in
other cell models (26, 67). Targeted disruption of MAPK-activated protein kinase, a substrate for p38 and ERKs, increases
susceptibility of mice to L. monocytogenes infection (68). Our
data suggest another role for MAPKs, promoting cPLA2␣ activation, in regulating immune responses to L. monocytogenes.
We previously reported that engagement of TLR2 is not sufficient for cPLA2␣ activation. The TLR2 ligand MALP2 poorly
induces arachidonic acid release but acts synergistically with
the dectin-1 agonist particulate ␤-glucan (69). Therefore it is
likely that engagement of an unknown receptor by L. monocytogenes, on resident peritoneal macrophages, mediates internalization and induces signals for cPLA2␣ activation cooperatively with TLR2. We found that internalization of WTLM and
⌬hlyLM is blocked by inhibition of PI 3-kinase and actin polymerization, and to a lesser extent by chelating extracellular calcium. Uptake of L. monocytogenes into nonphagocytic cells is
mediated in part by internalin A and internalin B, which interact with E-cadherin and Met receptors on host cells, respectively
(70, 71). Internalin B binding to the tyrosine kinase receptor Met
mediates internalization of L. monocytogenes through activation of
PI 3-kinase, MAPK, and actin polymerization (3, 24, 65, 70).
Internalin B also exhibits divalent-cation dependent binding to
C1q-R, the receptor for the complement component C1q that is
expressed on many cells, including peritoneal macrophages (72,
73). In J774 macrophages, internalin B mediates activation of Ras
and PI 3-kinase, and internalin A mediates phagocytosis of L.
monocytogenes (74, 75). However, we found that mutant L. monocytogenes lacking both internalin A and internalin B stimulates
arachidonic acid release in resident peritoneal macrophages as
effectively as WTLM (data not shown) suggesting that the internalins are not involved in mediating cPLA2␣ activation.
L. monocytogenes induces transcriptional responses in macrophages by interaction of cell wall components with pattern
recognition receptors such as TLRs, and by MyD88-independent mechanisms that are triggered by escape into the cytosol
(76). The cytosolic specific transcriptional response induced by
WTLM but not ⌬hlyLM, in bone marrow-derived macrophages, involves activation of p38 (77). In contrast, our results
demonstrate that WTLM and ⌬hlyLM both stimulate the TLR2dependent early activation of ERKs and p38 in resident peritoneal macrophages. Activation of MAPKs is not completely
ablated in TLR2- or MyD88-deficient resident peritoneal macrophages implicating a role for another signaling pathway independent of cytosolic sensing. In addition, ⌬hlyLM induces
similar levels of COX2 expression as WTLM by a TLR2-independent mechanism. The results demonstrate that the signals
induced by L. monocytogenes for eicosanoid production, including acute activation of cPLA2␣ and up-regulation of COX2, are
not dependent on cytosolic sensing and involve TLR2-dependent and -independent pathways. The data implicate the presence of another signaling pathway triggered by interaction of L.
monocytogenes with a receptor on macrophages that remains to
be identified.
The production of eicosanoids by resident peritoneal macrophages infected with L. monocytogenes was dependent on
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cPLA2␣. Therefore a comparison of macrophages from cPLA2␣
knock-out and wild type mice provided a model system to
determine whether production of eicosanoids influences macrophage responses to L. monocytogenes infection. WTLM
induced a similar degree of cytotoxicity in cPLA2␣⫹/⫹ and
cPLA2␣⫺/⫺ macrophages 24 h after infection despite incubation in medium containing gentamicin (data not shown). This
suggests that cPLA2␣ activation does not influence escape,
intracellular growth, and killing of resident peritoneal macrophages by WTLM.
A comparison of the ability of cPLA2␣⫹/⫹ and cPLA2␣⫺/⫺
macrophages to internalize WTLM revealed a small (25%) but
significant decrease in uptake of WTLM by cPLA2␣⫺/⫺. We
found opposing effects of adding PGE2 and LTC4 on internalization of WTLM. PGE2 blocked uptake of WTLM consistent
with a previous report showing a decrease in phagocytosis of
WTLM by peritoneal macrophages as determined by microscopic evaluation (22). The lack of PGE2 production by
cPLA2␣⫺/⫺ would be expected to result in increased WTLM
uptake, which was not observed. Addition of LTC4 to
cPLA2␣⫹/⫹ macrophages slightly increased phagocytosis of
WTLM, a trend similar to that observed for phagocytosis of K.
pneumoniae by rat alveolar macrophages (33). However, LTC4
addition did not reverse the defective ability of cPLA2␣⫺/⫺
peritoneal macrophages to internalize WTLM. cPLA2␣ initiates the production of numerous COX and lipoxygenase-derived lipid mediators that can differentially effect cellular
responses depending on the profile of eicosanoid receptor
expression. Therefore, it is unlikely that the decrease in phagocytosis of WTLM by cPLA2␣⫺/⫺ macrophages can be ascribed
to the loss of one particular lipid mediator.
We found that cPLA2␣ activation influences TNF␣ production, a cytokine essential for combating L. monocytogenes infection (78 – 80). cPLA2␣⫹/⫹ macrophages produced significantly
less TNF␣ than cPLA2␣⫺/⫺ macrophages. The ability of indomethacin to enhance production of TNF␣ in cPLA2␣⫹/⫹ macrophages to the level produced by cPLA2␣⫺/⫺ macrophages in
response to L. monocytogenes suggests that prostaglandins act
in an autocrine fashion to suppress TNF␣ production. It has
been reported that TNF␣ production by human and mouse
macrophages, including Kupffer cells, is suppressed by exogenous addition of prostaglandins and enhanced by blocking
endogenous prostaglandin production with cyclooxygenase
inhibitors (35– 43). We show that this regulatory program is
initiated by the activation of cPLA2␣ in response to L. monocytogenes infection. The receptors for PGE2 (EP2 and EP4) and
PGI2 (IP) mediate increases in cAMP, which down-regulates
TNF␣ production (35, 42, 81). It has been shown that treatment
with indomethacin increases susceptibility of mice infected
intraperitoneally with L. monocytogenes suggesting that prostaglandins or thromboxane A2 has a protective role (82). In
contrast, administering PGE1 suppresses cellular immunity in
mice infected intravenously with L. monocytogenes (83). It is
difficult to reconcile the role of COX-derived metabolites from
these studies because of the differences in route of infection and
use of indomethacin, which blocks production of all prostanoids and thromboxane A2, versus using a single prostaglandin.
However, they do point to a role for lipid mediators in regulat-
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ing immune response to L. monocytogenes. Prostaglandins may
have multiple effects in regulating immunity. In addition to
affecting TNF␣ levels, prostaglandins suppress production of a
variety of chemokines. They also up-regulate IL-10 and IL-6
production (36, 84, 85) and will have differential effects that
depend on the types of prostaglandin receptors expressed on
target cells (86). In addition to regulating cytokine production,
prostaglandins promote increases in vascular permeability and
blood flow, which regulate the migration of effector cells from
the blood to the site of infection (86). Our results demonstrate
that regulation of cytokine production by prostaglandins
occurs as a result of cPLA2␣ activation by L. monocytogenes,
suggesting that its early activation in tissue macrophages may
have an impact on immune responses to microbial infection.
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